State of Wisconsin Investment Board
DSGN icon

State of Wisconsin Investment Board’s Design Therapeutics DSGN Stock Holding History

State of Wisconsin Investment Board’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$524K Sell
49,214
-1,443
-3% -$14.6K ﹤0.01% 1977
2025
Q4 		$475K Buy
50,657
+23,595
+87% +$185K ﹤0.01% 1971
2025
Q3 		$204K Sell
27,062
-1,600
-6% -$8.01K ﹤0.01% 2258
2025
Q2 		$96.6K Buy
28,662
+6,700
+31% +$25.1K ﹤0.01% 2272
2025
Q1 		$84.8K Buy
+21,962
New +$105K ﹤0.01% 2186
2023
Q3 		– Sell
-84,000
Closed -$529K – 2533
2023
Q2 		$529K Buy
84,000
+40,900
+95% +$250K ﹤0.01% 1798
2023
Q1 		$249K Buy
+43,100
New +$322K ﹤0.01% 2180
2022
Q2 		– Sell
-35,600
Closed -$575K – 2828
2022
Q1 		$575K Buy
35,600
+18,200
+105% +$279K ﹤0.01% 1759
2021
Q4 		$373K Hold
17,400
– – ﹤0.01% 1789
2021
Q3 		$256K Hold
17,400
– – ﹤0.01% 2027
2021
Q2 		$346K Buy
+17,400
New +$439K ﹤0.01% 1844

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State of Wisconsin Investment Board's DSGN Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Design Therapeutics (DSGN) stake by 2.8% in Q1 2026, selling an estimated $14.6K and leaving 49,214 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

State of Wisconsin Investment Board first reported a position in DSGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $575K in Q1 2022. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • State of Wisconsin Investment Board held 49,214 shares of Design Therapeutics worth $524K as of Q1 2026.
  • State of Wisconsin Investment Board sold 1,443 Design Therapeutics shares in Q1 2026, an estimated $14.6K.
  • Design Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1977 holding.
  • State of Wisconsin Investment Board first reported a position in Design Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • State of Wisconsin Investment Board's Design Therapeutics position peaked at $575K in Q1 2022.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.